Avita Medical | 1811094D - Interest Expense On Debt



Avita Medical reported AUD1.35M in Interest Expense on Debt for its fiscal semester ending in June of 2024.


Interest Expense On Debt Change Date
Celltrion KRW 17.04B 1.34B Mar/2025
Clinuvel Pharmaceuticals 2.43M 414.48K Jun/2024
Cochlear AUD 5.7M 800K Dec/2024
CSL USD 240M 18M Dec/2024
Cspc Pharmaceutical 10.38M 934K Dec/2024
Dianthus Therapeutics 4.44M 263K Sep/2024
Divis Laboratories Ltd 30M 20M Jun/2025
Kangmei Pharma CNY 1.67M 1.45M Mar/2025
Knight Therapeutics CAD 1.91M 369K Sep/2024
Laboratorios Farma 699K 666.2K Jun/2025
Mayne Pharma AUD 1.2M 50K Jun/2024
Medical Developments International AUD 21K 23K Jun/2024
Nanosonics AUD 313K 73K Jun/2024
Neuren Pharmaceuticals 0 0 Jun/2024
Paradigm Biopharmaceuticals AUD 4K 2.48K Jun/2024
Polynovo AUD 178K 131K Jun/2024
PYC Therapeutics AUD 6K 30.66K Jun/2024
Qiagen NV USD 7.6M 311K Jun/2025
Ramsay Health Care AUD 305.7M 700K Dec/2024
ResMed USD 775K 886K Dec/2024
Sartorius 41.4M 51.4M Jun/2025
Sino Biopharmaceutical CNY 76.87M 114.23M Jun/2024
Telix Pharmaceuticals AUD 3.39M 2.92M Dec/2024
Tilray USD 7.77M 2.08M Nov/2024
Zz Pientze Pharmaceu 46.05M 36.5M Jun/2025